Delivery Order SPE2DB24D8002-SPE2DB24FJMNN
Award Date
7/15/24
Potential Completion Date
7/16/24
Potential Value
$6.7K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide 90 tablets of the prescription medication Jardiance 10 mg. The contract has a ceiling value of $4,835.60 and a performance period that runs through October 17, 2024. The award is not associated with a set-aside program. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $4,703.89 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product, with a period of performance through November 25, 2024. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. The IDC...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $27,657.68 firm fixed-price contract is for the delivery of Jardiance 10 mg tablets over a performance period ending on November 20, 2024. The contract was not set aside for any specific business category. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $5,461.21 Firm Fixed Price contract is for the delivery of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of December 14, 2023. Dakota Drug, Inc. is a key supplier to the DLA's Troop Support Medical division, providing a wide range of pharmaceutical and medical products to support U.S. Armed...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $6,776.14 firm fixed-price contract is for the delivery of the pharmaceutical product JARDIANCE 10 MG TABLET 90S. The contract has an ultimate completion date of May 30, 2024. Dakota Drug, Inc. is a key supplier for the DLA, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) as part of the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $16,111.10, is for the delivery of the pharmaceutical product Jardiance 25 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of November 22, 2023. This award is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA,...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $14,001.99, is for the delivery of the pharmaceutical product JARDIANCE 25 MG TABLET 90S. The contract has a period of performance through November 14, 2024 and is not a set-aside award. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of Jardiance 25 mg tablets. The $18,252.90 firm fixed-price contract has an ultimate completion date of January 23, 2024. Dakota Drug, Inc. is an experienced federal contractor, holding a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00, to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a small disadvantaged business. The contract, valued at $3,900.47, is for the delivery of Jardiance 10 mg tablets to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, to provide a comprehensive range of pharmaceutical products, medical supplies, and...
This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $5,915.31 firm fixed-price contract is for the delivery of Jardiance 10 mg tablets to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to provide a...